Treatment options for each of our patients can vary greatly depending on several factors such as how advanced the condition is when diagnosed or relapsed, specific molecular tumor tissue markers and the patients’ general health. At the GMI Prostate Cancer Center the departments of Radiology, Nuclear Medicine and Pathology apply the most modern diagnostic procedures to ensure an optimal diagnostic work-up. For example, the only positron-emission tomography / computed tomography (PET/CT) scanner available in the region is at the GMI Prostate Cancer Center. It is frequently used to accurately assess the spread of the disease. For this purpose, we apply a new imaging technique called prostate-specific membrane antigen (PSMA) PET imaging. In this test, a radioactive tracer (for example the modern PSMA tracer 18F-PSMA-1007) is injected intravenously, which then attaches to PSMA proteins on the tumor cells. 

The GMI Prostate Cancer Center offers a variety of treatment options. These include high-precision radiation therapy, minimally invasive surgery, access to clinical trials, hormone therapy, and chemotherapy. Specifically in the field of high-precision radiotherapy, the GMI team is a pioneer and one of the leading centers in Europe. By applying the most modern techniques such as high-dose rate brachytherapy or stereotactic-body radiotherapy, the prostate and the intraprostatic cancer mass can be treated with millimeter accuracy. Through these treatments, the adjacent organs like the rectum and the bladder are spared. A novel treatment option for patients with more advanced stages of the disease is the so called PSMA radioligand therapy. To determine the best possible cancer treatment and care plan, our multidisciplinary team of experts meet weekly at the GMI urologic malignancies tumor board.